Peer-reviewedCC BYFrontiers in oncology16 Oct 2026

Correlation between circulating tumor cell levels and tumor response in patients with advanced hepatocellular carcinoma undergoing immunotherapy and molecular targeted therapy

Jiangmin Zhou¹
Huifang Xiong²
Honghao Zhou³
Wei Wang¹
Cheng Zhou¹

¹Department of Hepatobiliary Surgery, Wuhan Hospital of Traditional Chinese and Western Medicine , ,
²Department of Gastroenterology, People’s Hospital of Dongxihu District , ,
³Department of Hepatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , ,

Immune and Circulating Biomarkers in Hepatocellular Carcinoma: Prognostic and Predictive Relevance for Immunotherapy
Fady Sidhom, Emin Karabiber, Rafik ElBeblawy +4
Cancers23 Oct 2026Peer-reviewedCC BY 4.0OncologyCrossref
A tumor–immune balance index from stem-like circulating tumor cells is associated with outcomes after yttrium-90 radioembolization for hepatocellular carcinoma
Chien-An Liu, Takatori Hideki, Tzu-Yuan Lin +4
Scientific Reports21 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
Circulating and tumor microenvironment immunomarkers associate with immunotherapy efficacy in advanced bladder urothelial carcinoma: an exploratory multicenter study integrating genomic and immunophenotypic profiling
Sha Liu, Junjun Lu, Zhaojie Lyu +7
Immunotherapy9 Oct 2026Peer-reviewedLicence not statedFull textOncologyPMC
Early Prognostic Value of the Freiburg Index of Post-Transjugular Intrahepatic Portosystemic Shunt Survival in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation
Yifan Ling, Jiaxin Zhao, Mengni Jing +3
Cureus16 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Prediction of Response to Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?
Mariana Verdelho Machado
Cancers1 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMCCrossref

Cite

BibTeX

@article{zhou2026correlation,
  title = {{Correlation between circulating tumor cell levels and tumor response in patients with advanced hepatocellular carcinoma undergoing immunotherapy and molecular targeted therapy}},
  author = {Jiangmin Zhou and Huifang Xiong and Honghao Zhou and Wei Wang and Cheng Zhou},
  journal = {Frontiers in oncology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13657974},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Correlation between circulating tumor cell levels and tumor response in patients with advanced hepatocellular carcinoma undergoing immunotherapy and molecular targeted therapy
AU  - Jiangmin Zhou
AU  - Huifang Xiong
AU  - Honghao Zhou
AU  - Wei Wang
AU  - Cheng Zhou
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in oncology
UR  - https://europepmc.org/article/PMC/PMC13657974
SN  - 2234-943X
ER  -

Related

Cite